Correlations of genetic resistance of chickens to Marek's disease viruses with vaccination protection and in vivo response to phytohemaglutinin by Gavora, JS et al.
Original article
Correlations of  genetic resistance
of  chickens to Marek’s disease viruses
with vaccination protection and in vivo
response to phytohemaglutinin
JS Gavora 1 JL Spencer I Okada 3 AA  Grunder
PS Griffin E. Sally 2
!  Agriculture Canada, Animal  Research Centre, Otta q vn,  Ontario, K1A OC6
2   Agriculture Canada, Animal  Diseases Research Institute,
Nepean, Ontario, Canada K2H  8P9
3  Faculty of  Applied Biological Science, Hiroshima University, Department of
Animal  Science, Higashi-Hiroshima, Japan
(Received 6 December 1989; accepted 17 September 1990)
Summary -  Twenty-three genetic groups of experimental and commercial meat and egg
chickens were injected with moderately virulent BC-1 (exp 1) or highly virulent RB-LB
(exp  2) Marek’s  disease (MD)  virus. Birds of  7  genetic groups  were  divided  into vaccinated
and  non-vaccinated groups and exposed by contact to the virulent RB-1B  virus in exp  3.
Response  to phytohemaglutinin (PHA)  injected in wing  webs  was  measured  in adult birds
of all 23 groups (exp 4) to assess its  relationship to MD  resistance. There was a high
correlation  (0.8) between resistance of the genetic groups to the two viruses indicating
that selection for resistance to one virus would be expected to improve resistance to the
other virus.  Regression of MD  incidence in vaccinated birds on that in non-vaccinated
birds resulted in regression coefficients of 0.41, 0.23, and 0.31% for males, females and
combined  sexes respectively, indicating that MD  incidence increased linearly in vaccinated
birds in relation to  their genetic  susceptibility to MD.  Two  significant correlations  in males
suggested that high swelling response to PHA  may  under some  conditions be associated
with MD  resistance. However, the correlation coefficients were inconsistent and it  was
concluded that swelling response to PHA  inoculated in the wing web  is not predictive of
MD  resistance.
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R.ésumé - Corrélations entre la  résistance génétique de poulets aux virus de la
maladie de Marek,  la  protection  de  la  vaccination  et  la  réaction  in  vivo  à  la
phytohémagglutinine.  Vingt-trois types génétiques de poulets, représentant des souches
«chair»  et «ponte» expérimentales et commerciales, ont été inoculés avec deux virus de
la Maladie de Marek: le  virus BC-1, modérément virulement (expérience 1) et le  virus
*   Animal Research Centre Contribution No  1652RB-1B, fortement virulent  (expérience  2).  Les sujets  de sept  types génétiques  ont été
repartis  en groupes vaccinés  et  non vaccinés  et  ont  été  exposés par contact au virus
virulent RB-1B  dans l’expérience 3. La réaction à la phytohémagglutinine (PHA)  injectée
dans les membranes alaires a été mesurée chez des sujets adultes des 23  types génétiques
(expérience 4) pour évaluer sa liaison  avec  la  résistance  à la  maladie de Mareck.  On
constate une forte  corrélation  (0.8)  entre  la  résistance  des  types  génétiques aux deux
virus,  ce  qui montre que la sélection pour la  résistance à un virus semble améliorer la
résistance  à  l’autre  virus.  La régression de la fréquence de la  maladie de Marek chez
les  sujets  vaccinés sur celle  des sujets non vaccinés  est  de 0.41; 0.23; 0.31 % pour les
mâles, les femelles et les deux sexes combinés respectivement, indiquant par là que, chez
les sujets vaccinés, la  fréquence de la maladie de Marek  augmente de  façon  linéaire avec les
sensibilités génétique à la maladie de Marek. Deux  corrélations significatives à l’injection
de PHA  peut, dans certains conditions,  être liée à la résistance à la maladie de Marek.
Cependant, les coefficients de corrélation sont contradictoires et les auteurs concluent que
la réaction de gonflement consécutive à l’inoculation de PHA  dans la membrane  alaire ne
peut servir à prédire la résistance à la maladie de Marek.
poulet / maladie de Marek  / vaccination / phytohémagglutinine
INTRODUCTION
Marek’s disease (MD) is  caused by a herpes virus that induces neoplastic trans-
formation of host T-cells, resulting in formation of lymphoid tumors. Protection
by vaccines is not complete and the combination of both vaccination and genetic
resistance is  required for optimum protection (Spencer  et  al,  1972, Gavora and
Spencer, 1979). Appearance of very virulent strains of MD  virus associated with
increased MD  losses in vaccinated flocks  (Witter, 1988) emphasizes the need to
improve vaccines and to increase levels of  genetic resistance.
In this context, questions of practical importance are (1)  whether genotypes
resistant to moderately virulent MD  viruses are also resistant to highly virulent
viruses, and  (2) what  is the degree of  protection by  vaccination against the virulent
viruses  in genotypes  that  differ in their  natural MD  resistance. Genetic  improvement
of resistance can be accomplished by direct selection based on response to MD
virus or,  more desirably,  on marker traits measurable without exposure to the
pathogen. Response of chickens to phytohemaglutinin (PHA) was considered a
potential marker  trait for this purpose.
T-cells play a dual role in the pathogenesis of MD,  in that they are both the
target cells for neoplastic  transformation, and  act with  natural  killer cells, in defence
against MD  tumors (Sharma et  al,  1977,  Sharma, 1981).  Susceptibility to MD
tumors may  be linked to strong cell-mediated immune  response and  is influenced
by  both age  and  genotype  of  the bird (Calneck, 1986) and MD  resistance  is, at least
partly, the property of  the target T-cells (Gallatin and Longenecker, 1979).
Response  of  chickens  to PHA  injected intradermally  is a  measure  of  cell-mediated
immunity involving T-cells (Goto et al,  1978), although the response is cellularly
heterogeneous (Edelman et al,  1986). Response of chickens to PHA  differs among
commercial  stocks (Van  der Zijpp, 1983), or  experimental  lines (Lamont  and  Smyth,
1984) and  is influenced by  both  sex and  major  histocompatibility haplotype (Taylor
et al,  1987).The  relationship of PHA  response and MD  resistance is not clearly understood.
A line of chickens selected  for  high plasma corticosterone had an impaired  in
vitro  response  of lymphocytes to PHA and greater MD tumor incidence  and
mortality than a low corticosterone line (Thompson et al,  1980). In contrast, Lee
and Bacon (1983)  reported that increased  in  vitro response of lymphocytes to
phytohemaglutinin was associated with increased susceptibility to MD.  However,
Calnek et al (1989) dit not observe any general correlation between the responses
of  multiple genetic groups  of  chickens to mitogens Concavalin A  and PHA  or mixed
lymphocyte reaction, and MD  susceptibility.
In this study, correlations between  resistance of  several  genetic groups  of  chickens
to two strains of MD  virus that differed widely in virulence were investigated and
the relationship between genetic resistance to MD  and protection by vaccination
was assessed. The  relationship of genetic resistance to MD  with swelling response
induced by the injection of PHA  into the wing web  is also reported.
MATERIALS  AND  METHODS
Chickens
A  description of the genetic groups used in  the study is  given in  table  I  and
the populations used are shown in figure 1. The  parental populations were rearedintermingled in floor pens and housed in individual cages as adults. They were
vaccinated for MD,  infectious bronchitis and Newcastle disease, as well as avian
encephalomyelitis, and were  fed mash  rations throughout their lifetime. They  were
given  a uniform light  diet  in  all  generations. No major disease outbreak was
experienced in any of the parental flocks or the 1983 flock used for the PHA  test.
In all these flocks, rearing mortality was less than 8%  and laying house mortality
less than 10%. In addition to the above parents, parallel  specific pathogen-free
(SPF) parent populations for genetic groups CS, CK, and NH  were maintained on
a  filtered-air, positive-pressure building where they received no  vaccines and were
free of Marek’s disease virus and other avian pathogens.
Marek’s disease challenge tests (exp 1, 2 and  3)
For the MD  challenge tests the birds were in  floor pens in an isolation facility
(Grunder et al, 1972). At  3 weeks  of  age, each bird was  inoculated intraperitoneally
with the respective MD  virus isolant. In exp 1, the inoculum contained the BC-1
virus (Spencer et al, 1972) and  the birds produced  from both  conventionally housed
and SPF  parents were observed for 63 d after inoculation. In exp 2 the inoculum
was  the RB-1B  virus (Schat et al, 1981) and  the  duration was  56  d  after inoculation.
The  inocula for both experiments were from lots of cell-associated virus stored in
liquid nitrogen that had previously been tested for pathogenicity.
Exp  3 included 130 to 147 birds from each of  7  genetic groups (A,3R,7,8,8R,CS,
and CK). Approximately half of these birds were vaccinated on the day of hatch
with 6000 plaque-forming  units of  cell-associated herpes virus of  turkeys. The  birdswere kept in  isolation  until  14 d of age and were then exposed to seeder birds
previously infected with the RB-1B virus. The  birds were killed at 53 d after the
exposure.
All birds that died or were killed because of illness,  and survivors that were
killed at termination of the tests, were necropsied. MD  incidence was based on
gross lesions.
Phytohemaglutinin (PHA)  response test (Exp  4)
The  dose and  inoculation site for this experiment was determined on the basis of a
preliminary  test using 30  adult White  Leghorn  females and 12 adult White  Leghorn
males inoculated with 75, 500 and 1250 mg  of PHA  per bird in the wattle or wing-
web. Wing webs were found easier to measure as wattles tended to be soft and
pliable. Of  the doses  tested, 500 and 1250 mg  gave similar swelling responses  in the
wing  web.
The  procedure used in exp 4 was  similar to that of Van  der Zijpp (1983). Adult
birds (482 d of age at PHA  inoculation) were each inoculated intradermally with
0.125 ml  of  phosphate  buffered saline (PBS)  in the  left wing  web. The  same  volume
of  PBS  containing 500 mg  PHA *   was  inoculated in the  right wing  web. Prior to the
inoculation the wing webs were plucked free of feathers and the inoculation sites,
close to but not on the edge of the web  were marked with a  felt pen.
Thickness of the wing web was measured before inoculation, as well as 24 and
48 h  after inoculation, using Miluyo  electronic micrometer, model No  293-701 that
applied constant  pressure on all  wing webs, independent of the operator.  The
swelling index (I) was  calculated as
where  &dquo;T&dquo;  is  the thickness and subscripts  &dquo;R&dquo;  and  &dquo;L&dquo;  indicate the right  and
left  wing web and  &dquo;1&dquo;  and  &dquo;2&dquo;  indicate thickness before and after inoculation,
respectively.
Statistical analyses
Spearman’s rank and  Pearson’s product-moment correlation between resistance to
the BC-1 and RB-1B viruses and PHA  response were calculated on the basis of
genetic group means. The  dependence of MD  incidence in vaccinated birds on MD
incidence in non-vaccinated birds was assessed by linear regression using genetic
group means. MD  incidence among  genetic groups and  vaccination treatments was
compared by homogeneity X 2  tests and differences between grouping of genetic
groups by the student’s  t-test.  Individual bird  swelling index data after PHA
challenge were  subjected to  analysis of  variance  using  a  model  containing the  effects
of  genetic group, sex and their interaction.
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Resistance to the BC  and  RB-LB  isolants of MD  virus
MD  incidence after challenge with the BC-1 and the RB-1B  isolants of MD  virus
differed widely  in exp 1 and  2 (table II). In exp  1, the  overall MD  incidence induced
by  BC-1  was  close to 15%  and  this was  significantly lower (P  <  0.01) than  the 47%
MD  incidence induced by RB-1B  in exp 2.
The ranges of MD  incidence among the genetic groups tested were from 0 to
46.4% in males and  0 to 89.7% in females in exp 1, and  from 5.7 to 93.7% in males
and from  4.1 to 97.2% in females in exp 2. In genetic groups 8R, XP02, and XP21
there was no incidence of MD  after BC-1 challenge while MD  was observed in all
genetic groups after challenge with RB-LB (table II). Among  the birds challenged
with BC-1 there was a significant sex difference (P <  0.05), the incidence being
11.5% higher  in females than  in males. The  corresponding  sex difference of  4.2% in
birds challenged with RB-1B was not statistically significant. With the exception
of strain NH  females, MD  incidence in strains CS, CK, and NH  in exp 1 was not
significantly different between birds produced from  conventionally and SPF  housed
dams.
The  relationship between resistance of  the genetic groups to the BC-1 and RB-
1B challenge was expressed in terms of Spearman’s rank and Pearson’s product-
moment  correlations (table III). the correlations for males and females separately,
as well as for sexes combined were all high and significant, although correlations
tended to be higher in females.
Relationship of  genetic resistance to MD  and  vaccination protection
Incidence of Marek’s disease in the non-vaccinated birds exposed by contact to
RB-LB in exp 3 at 2 weeks of age (fig 2) was in good agreement with that in the
same genetic groups challenged by injection at 3 weeks of age in exp 2 (table II),
although  the  average MD  incidence  in contact challenge was  6.6%  lower. Vaccination
conferred significant protection (P <  0.05) to both males and females and there
were high and  significant correlations between MD  incidence in the vaccinated and
non vaccinated birds (table III).
Linear regressions were  fitted for the relationship between MD  incidence in non-
vaccinated  birds. The  regression accounted  for 92, 68  and  95%  of  total variation (R 2 )
for males, females and sexes combined. The  respective regression coefficients were
0.41, 0.23, and  0.31 for males,  females and  sexes combined.  Thus,  in this experiment,
MD  incidence  in vaccinated birds increased linearly with their genetic susceptibility
(fig 2) and  a  combination  of  genetic resistance with vaccination resulted in the best
protection.
Marek’s disease resistance and  response to phytohemaglutinin
The means of the swelling index measured at 24 h after injection with PHA  are
shown in table II.  The mean swelling at 48 h post injection and the differences
between the 48 h and 24 h swelling were also calculated but are not shown in the
table. Although the time of peak response was not determined, the 24 h responsewas, as a rule, greater than that of 48 h. There were highly significant differences
among  the genetic groups and sexes and genetic group by sex interaction was also
significant for the 24 h index (table IV). The mean swelling at 24 h was larger
in males than in females. Nevertheless, in 5 out of the 23 groups, females showed
a greater swelling than males - hence the significant interaction. For the swelling
index measured at 48 h, the overall effect of sex was no longer significant but the
effect of  genetic  group  and  its interaction with  sex reached  statistical significance. Incomparisons between sexes, the greater swelling was in males in 11 genetic groups
and  in females  in 12 genetic groups. The  tendency was  for swelling to develop more
slowly and to peak  later in females than in males.
Rank-order and product-moment correlations of MD  incidence and wing web
swelling after PHA  inoculation are shown in table V. Only the negative correla-
tions of the 48 h swelling index of males with MD  resistance reached statistical
significance. The  remaining  correlations of  24 h and 48 h swelling indices for males
were  also negative, while those for females were  inconsistent in both sign and mag-
nitude.
DISCUSSION
Incidence of Marek’s disease among  the genetic groups in both exp 1 and 2 varied
widely and in exp 2 spanned almost the entire range from 0 to 100% (table II).
The  incidence of MD  lesions was described in more  detail by Spencer et al (1984)showing that the predominant lesion in BC-1 inoculated females was in the ovary
and in males in nerves. The RB-1B virus induced a high proportion of visceral
lesions in both males and females. As observed previously (Grunder et al,  1972),
BC-1 induced a higher incidence of MD  in females than males. No  significant sex
difference was observed in MD  incidence after RB-1B challenge.  This, together
with the large difference between the overall MD  incidences after BC-1 and RB-
1B challenge, emphazises the genetic divergence between the two virus strains.
The  correlations between resistance to the MD  viruses (table III), as well as that
between this resistance and PHA  (table V), express genetic relationships because
the correlations are based on means of the genetic groups, which are themselves
genetic characteristics.
Since there were high  correlations  between resistance  to BC-1 and RB-1B,
selection for resistance to one of the viruses would also be expected to improve
resistance to the other. This conclusion was supported by comparisons of related
genetic groups that  have undergone various degrees of selection.  There were 3
such sets of  genetics groups of Leghorns, each originating from a  different genetic
base population (table I). The  sets consisted each of a  strain selected for high egg
production,  egg  weight and  related economically  important  traits including  viability
(P-strains), and  of  strains selected  for resistance to the  BC-1  virus  in addition to the
above  traits (R-strains). Selection  for resistance to  the  BC-1  significantly  (P <_  0.01)
improved resistance of the R-strains 3R  and the 8R  to the RB-1B  virus compared
with their respective P-strain counterpart strains 1 and 8 (table II). In the third
set, there was no  significant difference between the P-strain 2 and R-strain 2R  in
RB-1B  resistance.
Our results  from  lines  XP02 and XP21 confirm  the  resistance  of the  B2i
haplotype (XP21) and B 2   haplotype (XP02) against multiple MD  viral  strains
(Gavora et al,  1986; Bacon 1987). The commercial stocks differed widely in MD
resistance: Leghorn stock A  was among  the most resistant group, however, stocks
B and C  were  far more  susceptible (table II).
The linear relationship between genetic resistance to MD  and protection by
vaccination (fig 2) was based on only 7 genetic groups but should have a broad
validity for the virus strain and vaccine type tested, as the resistance of the non-
vaccinated groups practically spanned  0 to 100%. The  positive correlation between
resistance  to  the RB-LB  and  BC-1  isolants of MD  virus suggest that the  relationship
of MD  resistance and protection by vaccination may  also be valid for other MD
viruses.
In the determination of the PHA  swelling index, possible differences in wing
web thickness of the right and left wing or the variation in the response to PBS
were not considered as it was shown  that they  are negligible (Van der Zijpp, 1983).
Overall, the levels of  response  to PHA  in this study  were  lower than  those observed
by Van der Zijpp (1983) and Lamont and Smyth (1984). This discrepancy may  be
due to the lower dose of PHA  and older age of the birds in this study, as well as
the genotypes of birds tested. Similar to the present study, Van der Zijpp (1983),
Lamont  and Smyth  (1984), as well as Goto et al (1978) used conventionally housed
birds for the PHA  inoculation experiments.
The  correlations of MD  incidence with PHA  response (table V) were generally
low and inconsistent. The two correlations that were significantly different fromzero, as well as the sign of 7 out of the 8 correlations for sexes combined in the
table,  suggested a tendency for  the high PHA response to be associated with
MD  resistance. Consistent with the observations of Thompson et al (1980), this
would  indicate that the bird’s ability to mount a  cell-mediated immune  response  is
important for MD  resistance.
Of  the three sets of R- and P-strains, described, for combined sexes,  the R-
strains 2R  and 3R  had greater PHA  response than the corresponding P-strains 2
and 1  (table II). The reverse was observed for the third set of R-strains 8R  and
P-strains 8. In addition most of the correlations between PHA  response and MD
resistance were  non  significant (table V). Therefore, in agreement with Calnek et al
(1989), who  studied in vitro PHA  response of  lymphocytes from strains of  varying
resistance to MD, we conclude that swelling response to PHA  inoculation in the
wing  web  is not sufficiently predictive of MD  resistance to  justify its use in genetic
selection.
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